Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats - PubMed

Affiliations

• PMID: 15605375
• DOI: 10.1002/jnr.20345

Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats

Ravinder Pannu et al. J Neurosci Res. 2005.

Abstract

Spinal cord injury (SCI) is a devastating and complex clinical condition involving proinflammatory cytokines and nitric oxide toxicity that produces a predictable pattern of progressive injury entailing neuronal loss, axonal destruction, and demyelination at the site of impact. The involvement of proinflammatory cytokines and inducible nitric oxide synthase (iNOS) in exacerbation of SCI pathology is well documented. We have reported previously the antiinflammatory properties and immunomodulatory activities of statins (3-hydroxy-3-methylglutaryl [HMG]-CoA reductase inhibitors) in the animal model of multiple sclerosis, experimental allergic encephalitis (EAE). The present study was undertaken to investigate the efficacy of atorvastatin (Lipitor; LP) treatment in attenuating SCI-induced pathology. Immunohistochemical detection and real-time PCR analysis showed increased expression of iNOS, tumor necrosis factor alpha (TNFalpha) and interleukin 1beta (IL-1beta) after SCI. In addition, neuronal apoptosis was detected 24 hr after injury followed by a profound increase in ED1-positive inflammatory infiltrates, glial fibrillary acidic protein (GFAP)-positive reactive astrocytes, and oligodendrocyte apoptosis by 1 week after SCI relative to control. LP treatment attenuated the SCI-induced iNOS, TNFalpha, and IL-1beta expression. LP also provided protection against SCI-induced tissue necrosis, neuronal and oligodendrocyte apoptosis, demyelination, and reactive gliosis. Furthermore, rats treated with LP scored much higher on the locomotor rating scale after SCI (19.13 +/- 0.53) than did untreated rats (9.04 +/- 1.22). This study therefore reports the beneficial effect of atorvastatin for the treatment of SCI-related pathology and disability.

Similar articles

• Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.

  Pannu R, Christie DK, Barbosa E, Singh I, Singh AK. Pannu R, et al. J Neurochem. 2007 Apr;101(1):182-200. doi: 10.1111/j.1471-4159.2006.04354.x. Epub 2007 Jan 8. J Neurochem. 2007. PMID: 17217414

• Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats.

  Yune TY, Lee JY, Cui CM, Kim HC, Oh TH. Yune TY, et al. J Neurochem. 2009 Aug;110(4):1276-87. doi: 10.1111/j.1471-4159.2009.06214.x. Epub 2009 Jun 10. J Neurochem. 2009. PMID: 19519665

• Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury.

  Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA. Festoff BW, et al. J Neurochem. 2006 Jun;97(5):1314-26. doi: 10.1111/j.1471-4159.2006.03799.x. Epub 2006 Apr 21. J Neurochem. 2006. PMID: 16638021

• Inflammation and apoptosis: linked therapeutic targets in spinal cord injury.

  Beattie MS. Beattie MS. Trends Mol Med. 2004 Dec;10(12):580-3. doi: 10.1016/j.molmed.2004.10.006. Trends Mol Med. 2004. PMID: 15567326 Review.

• Degenerative and regenerative mechanisms governing spinal cord injury.

  Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Profyris C, et al. Neurobiol Dis. 2004 Apr;15(3):415-36. doi: 10.1016/j.nbd.2003.11.015. Neurobiol Dis. 2004. PMID: 15056450 Review.

Cited by

• Acute injury in the peripheral nervous system triggers an alternative macrophage response.

  Ydens E, Cauwels A, Asselbergh B, Goethals S, Peeraer L, Lornet G, Almeida-Souza L, Van Ginderachter JA, Timmerman V, Janssens S. Ydens E, et al. J Neuroinflammation. 2012 Jul 20;9:176. doi: 10.1186/1742-2094-9-176. J Neuroinflammation. 2012. PMID: 22818207 Free PMC article.

• Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.

  Li B, Mahmood A, Lu D, Wu H, Xiong Y, Qu C, Chopp M. Li B, et al. Neurosurgery. 2009 Jul;65(1):179-85; discussion 185-6. doi: 10.1227/01.NEU.0000346272.76537.DC. Neurosurgery. 2009. PMID: 19574840 Free PMC article.

• Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

  Mortazavi MM, Verma K, Deep A, Esfahani FB, Pritchard PR, Tubbs RS, Theodore N. Mortazavi MM, et al. Childs Nerv Syst. 2011 Aug;27(8):1307-16. doi: 10.1007/s00381-010-1365-x. Epub 2010 Dec 21. Childs Nerv Syst. 2011. PMID: 21174102 Review.

• Molecular mechanisms underlying the effects of statins in the central nervous system.

  McFarland AJ, Anoopkumar-Dukie S, Arora DS, Grant GD, McDermott CM, Perkins AV, Davey AK. McFarland AJ, et al. Int J Mol Sci. 2014 Nov 10;15(11):20607-37. doi: 10.3390/ijms151120607. Int J Mol Sci. 2014. PMID: 25391045 Free PMC article. Review.

• Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury.

  Wu H, Mahmood A, Lu D, Jiang H, Xiong Y, Zhou D, Chopp M. Wu H, et al. J Neurosurg. 2010 Sep;113(3):591-7. doi: 10.3171/2009.9.JNS09859. J Neurosurg. 2010. PMID: 19895202 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal